5-Methylmethiopropamine

5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]

5-Methylmethiopropamine
Legal status
Legal status
Identifiers
  • N-methyl-1-(5-methylthiophen-2-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC9H15NS
Molar mass169.29 g·mol−1
3D model (JSmol)
  • CC1=CC=C(S1)CC(C)NC
  • InChI=1S/C9H15NS/c1-7(10-3)6-9-5-4-8(2)11-9/h4-5,7,10H,6H2,1-3H3
  • Key:HZICDJQMPRFRKC-UHFFFAOYSA-N

See also

References
  1. EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.
  2. "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
  3. New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.